Endo-BCN-PEG4-Pomalidomide

Endo-BCN-PEG4-Pomalidomide is a PEG derivative composed of BCN, PEG4 and Pomalidomide (HY-10984) . The BCN groupis very reactive with azide-tagged molecules. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc[1].

Product Specifications

UNSPSC

12352200

Hazard Statement

H302-H315-H319-H335

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Others

Smiles

[H][C@]12C([C@@H]2COC(NCCOCCOCCOCCOCC(NC3=CC=CC(C(N4C5CCC(NC5=O)=O)=O)=C3C4=O)=O)=O)([H])CCC#CCC1

Molecular Formula

C34H42N4O11

Molecular Weight

682.72

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Pasieka A, et al. Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists? ChemMedChem. 2023 Oct 17;18 (20) :e202300422.